GlassScriptPhysician profile
Robert Frangie
NPI 1912496001
$41,506.93
in general payments reported to CMS, 2019-2025
11 companies · $3,782 in 2025
The $3,782 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $4,750 · 2021: $18K · 2022: $10K · 2023: $3,605 · 2024: $1,594 · 2025: $3,782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,293 · Travel and Lodging: $3,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,292.83 |
| Travel and Lodging | $3,688.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15,144.27 | 2021-2022 | |
| Arthrex, INC. | $10,985.81 | 2021-2024 | Knee & Hip Implants Acl Backup |
| Stryker Corporation | $7,790.81 | 2020-2025 | Mako, Triathlon, Insignia |
| Medinc of Texas | $6,170.37 | 2020-2025 | |
| Orthalign INC | $417.03 | 2022-2024 | Orthalign Plus |
| Microport Orthopedics INC | $260.93 | 2025 | Mpo Medial Pivot Knee |
| Becton, Dickinson and Company | $181.45 | 2024 | Channel Drain |
| Sanara Medtech INC. | $148.42 | 2024 | Celleraterx |
| Zimmer Biomet Holdings, INC. | $146.21 | 2022 | |
| Davol INC. | $138.22 | 2025 | Arista |
| Total Joint Orthopedics, INC. | $123.41 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Frangie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.